Inspire Investing, LLC Amicus Therapeutics, Inc. Transaction History
Inspire Investing, LLC
- $858 Million
- Q4 2024
A detailed history of Inspire Investing, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 43,151 shares of FOLD stock, worth $414,681. This represents 0.05% of its overall portfolio holdings.
Number of Shares
43,151
Previous 70,673
38.94%
Holding current value
$414,681
Previous $754,000
46.15%
% of portfolio
0.05%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
312MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$277 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$270 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$234 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$230 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$223 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...